The rapid test Covid-19, Sars-Cov-2 is available via nasopharyngeal swab, via saliva and via whole blood, serum, plasma. The Sars-CoV-2 Antigen Rapid Test (Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS CoV-2 nucleocapsid protein antigens in the swab specimen of individuals with suspected SARS-CoV-2 infection in combination with the clinical presentation and the results of other laboratory tests. The Covid-19 Saliva Rapid Antigen Test (Oral Fluid) is a rapid chromatographic immunoassay test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in oral fluid samples from individuals with suspected SARS infection -CoV-2 in combination with clinical presentation and other laboratory test results. The 2019-nCoV IgG/IgM Rapid Test Cassette is a rapid, lateral flow immunochromatographic assay for the qualitative detection of 2019-nCov IgG and IgM antibodies in human fingerstick whole blood specimens. The SARS-CoV-2 Neutralizing Antibody Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid immunochromatographic test designed for the qualitative detection of neutralizing antibodies against SARS-CoV-2 that block the interaction between the domain that binds the viral spike glycoprotein receptor (RBD) and cell surface receptor ACE2 in human serum, plasma or whole blood. It is intended to be used as an aid in the identification of individuals with an adaptive immune response to SARS-CoV-2. The results indicate the detection of neutralizing SARS-CoV-2 antibodies. Positive results indicate the presence of neutralizing antibodies SARS-CoV-2.
